We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arcutis Biotherapeutics Inc | NASDAQ:ARQT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.14 | -1.58% | 8.70 | 8.70 | 8.71 | 9.2199 | 8.42 | 8.88 | 1,171,568 | 20:02:39 |
Delaware
|
001-39186
|
81-2974255
|
||||||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification Number)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||||||||||||
Common Stock, par value $0.0001 per share
|
ARQT
|
The Nasdaq Global Select Market
|
Exhibit No.
|
Description
|
|||||||
99.1 |
ARCUTIS BIOTHERAPEUTICS, INC.
|
|||||||||||
November 5, 2020 |
By:
|
/s/ John W. Smither
|
|||||||||
John W. Smither
|
|||||||||||
Chief Financial Officer
|
1 Year Arcutis Biotherapeutics Chart |
1 Month Arcutis Biotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions